Zarondan-Saft
Zarondan-Saft Brand names, Zarondan-Saft Analogs
- Aethosuximide
- Asamid
- Atysmal
- Capitus
- Emeside
- Epileo Petit Mal
- Ethosuccimide
- Ethosuccinimide
- Ethosuxide
- Ethymal
- Etomal
- Etosuximid
- Etosuximida
- Mesentol
- Pemal
- Pemalin
- Pentinimid
- Peptinimid
- Petinimid
- Petnidan
- Piknolepsin
- Pyknolepsinum
- Ronton
- Simatin
- Succimal
- Succimitin
- Suxilep
- Suximal
- Suxin
- Suxinutin
- Thetamid
- Thilopemal
- Uritone
- Urodeine
- Zaraondan
- Zarodan
- Zarondan
- Zarondan-Saft
- Zarontin
- Zartalin
Zarondan-Saft Brand Names Mixture
- No information avaliable
Zarondan-Saft Chemical_Formula
C7H11NO2
Zarondan-Saft RX_link
http://www.rxlist.com/cgi/generic2/ethosuximide.htm
Zarondan-Saft fda sheet
Zarondan-Saft msds (material safety sheet)
Zarondan-Saft Synthesis Reference
No information avaliable
Zarondan-Saft Molecular Weight
141.168 g/mol
Zarondan-Saft Melting Point
64.5 oC
Zarondan-Saft H2O Solubility
39.2 g/L
Zarondan-Saft State
Solid
Zarondan-Saft LogP
1.012
Zarondan-Saft Dosage Forms
Syrup
Zarondan-Saft Indication
For the treatment of petit mal epilepsy.
Zarondan-Saft Pharmacology
Used in the treatment of epilepsy. Ethosuximide suppresses the paroxysmal three cycle per second spike and wave activity associated with lapses of consciousness which is common in absence (petit mal) seizures. The frequency of epileptiform attacks is reduced, apparently by depression of the motor cortex and elevation of the threshold of the central nervous system to convulsive stimuli.
Zarondan-Saft Absorption
No information avaliable
Zarondan-Saft side effects and Toxicity
No information avaliable
Zarondan-Saft Patient Information
No information avaliable
Zarondan-Saft Organisms Affected
Humans and other mammals
